AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo.

Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.

Arkansas’ own statistics show much work to be done. Per a 2023 press release from the Arkansas Department of Health, nearly ...

A breast lump is the most common and recognized symptom of breast cancer, according to a 2023 study published in Preventive ...

Genetic testing is recommended for those with personal and family histories of several types of cancer — including pancreatic ...

As the cancer mortality rate continues to fall, incidence rates in the U.S. have increased at varying degrees across demographics and state lines, according to the American Cancer Society's annual ...

Cancer incidence continues to rise for many common cancers—especially for women. The incidence rate for women younger than 50 ...

Cancer diagnoses are shifting from older to younger adults and from men to women, according to a report released Thursday by ...

A new resource from the National Comprehensive Cancer Network (NCCN) provides evidence-based guidance on assessing and ...

Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug ...

Many women worry hormonal contraceptives have dangerous side-effects including increased cancer risk. But this perception is often out of proportion with the actual risks.

"I am officially done with radiation, which means I am officially done with what is considered active cancer treatment," ...